Clinical Trial Update: Neuroendocrine Mechanisms in Behavioral Treatment of Insomnia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating neuroendocrine mechanisms in the behavioral treatment of insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Insomnia | Phase 2 | Status: COMPLETED